Antithrombin alfa

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAntithrombin alfa
Drug Alias Name抗凝血酶αAntithrombin αRecombinant human antithrombin IIIAntithrombin III recombinant humanTransgenic antithrombin III +[12] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionFactor Xa inhibitorsThrombin inhibitors
TargetsProthrombinCoagulation factor X
Therapy Area/IndicationsPostoperative HemorrhageAntithrombin III Deficiency
Global Approved IndicationsAntithrombin III Deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2006/07/28
Country/TerritoryCanadaUnited StatesItaly +[9] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesRevo Biologics IncGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRevo Biologics IncLaboratoire Francais Du Fractionnement Et Des Biotechnologies
Active IndicationsN/A
Inactive IndicationsPostoperative HemorrhageAntithrombin III Deficiency

Other Information

ATC CodeB01AB02
Related LinksWikipediaDrugBankKEGG